Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 30.27 · gapped above the open, then crossed back over prior close. High/low 30.88 at 10:15 am ET, 30.14 at 11:15 am ET.
via Perceptive Advisors LLC, Adage Capital Partners GP, L.L.C., Commodore Capital LP +5 more · 5.44% of ANRO, 9.63% of SABS
via Commodore Capital LP, Spruce Street Capital LP, Vivo Capital, LLC +1 more · 9.21% of ANRO, 11.93% of ANTX
via Commodore Capital LP, Perceptive Advisors LLC, Spruce Street Capital LP +2 more · 9.21% of ANRO, 6.72% of RACC
via Commodore Capital LP, Perceptive Advisors LLC, Spruce Street Capital LP +1 more · 9.21% of ANRO, 6.39% of LONA
via Perceptive Advisors LLC, Spruce Street Capital LP, Vestal Point Capital, LP +5 more · 5.44% of ANRO, 4.90% of SRZN
via Adage Capital Partners GP, L.L.C., Commodore Capital LP, Franklin Resources Inc +5 more · 5.41% of ANRO, 4.96% of EYPT
Managers holding a meaningful stake in ANRO also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
116 institutional managers report a position in Alto Neuroscience, Inc. worth $780.4M between them, filed on form 13F for the quarter ending 2026-06-30. 20 of them hold 80% of it, the largest being Falcon Edge Capital LP at 12.54%.
91 more managers in the register
20 managers hold 80% of the $780.4M institutional base. The other 96 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
Alto Neuroscience, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Pharmaceutical Preparations
ANRO (Alto Neuroscience, Inc.) has 12 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: SNY −2.03%, in industrials & materials.